Durability of immune response against omicron BA.2 and BA.4/5 and T cell responses after boosting with mRNA and adenoviral vector-based vaccines following heterologous CoronaVac/ChAdOx-1nCov-19 vaccination

Durability of immune response against omicron BA.2 and BA.4/5 and T cell responses after boosting with mRNA and adenoviral vector-based vaccines following heterologous CoronaVac/ChAdOx-1nCov-19 vaccination

Heterologous vaccination with inactivated vaccine followed by adenoviral vector-based vaccine has shown superiority in enhancing immune response compared to homologous primary series. However, data comparing immunity decline after a third booster following heterologous CoronaVac/ChAdOx-1nCov-19 has...

Full description

Saved in:
Bibliographic Details
Main Authors: Nungruthai Suntronwong, Sitthichai Kanokudom, Thaksaporn Thatsanathorn, Thanunrat Thongmee, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Yong Poovorawan
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
SARS-CoV-2
omicron
mRNA vaccine
viral vectored
booster
heterologous
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2023.2283916
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/21645515.2023.2283916

Similar Items